PEKIN, Ill., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, announced that management plans to participate at the LD Micro Main Event XIX on Tuesday, October 21, 2025, in San Diego. Management will conduct one-on-one meetings, and management will present at 1:00 pm PT. Presentation materials and webcast for the presentation can be accessed at www.altoingredients.com. About Alto Ingr ...

New brands, including Cato Fashions, SCHEELS, Dermstore, and more, join Sezzle’s network as merchants prepare for peak holiday demand.Minneapolis, MN, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Sezzle Inc. (NASDAQ:SEZL) (Sezzle or Company) // Sezzle, a leading buy now, pay later (BNPL) platform, today announced an expanded roster of merchant partners across fashion, sporting goods, beauty, fitness, and digital content just in time for the 2025 holiday shopping season. Holiday budgets are under pressure. According to ...

Oral presentation will include the full 96-week and post-treatment follow up data from the Phase 1 monotherapy study of ALG-000184SOUTH SAN FRANCISCO, Calif., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced eight presentations, including one oral presentation, at The Liver Meeting® 2025, being held November 7 – 11, 2025 in ...

融资活动概述 - 公司宣布与多家机构投资者达成协议，行使现有认股权证，为公司带来约580万美元的总收益（扣除配售代理费用和预计发行费用前）[1] - 此次交易共行使了1,048,094份现有认股权证，这些权证分别于2022年10月25日、2024年7月21日和2025年7月2日发行[2] - Ladenburg Thalmann & Co Inc 担任此次交易的独家配售代理[2] 权证条款细节 - 现有认股权证的行使价格为每股5.25美元，同时权证持有者每份权证支付0.125美元以获得新权证[3] - 作为交换，行使方将通过私募获得1,048,094份未注册的Series I认股权证和1,048,094份未注册的Series II认股权证[3] - Series I和Series II认股权证发行后可立即行使，行使价格为每股6.00美元[3] - Series I认股权证的有效期为自首次行使之日起五年，Series II认股权证的有效期为18个月[3] - 这些权证不包含任何可变价格功能或反稀释条款[3] 资金用途 - 公司计划将此次发行的净收益用于营运资金和一般公司用途[4] - 部分资金将用于其化合物CLR 121125（CLR 125）在三阴性乳腺癌中的1b期临床研究[4] - 部分资金将用于向欧洲药品管理局（EMA）提交条件性上市许可（CMA）申请的准备工作[4] 公司业务与研发管线 - 公司是一家晚期临床生物制药公司，专注于独立及通过研发合作发现和开发用于治疗癌症的专有药物[7] - 公司的核心目标是利用其专有的磷脂药物偶联物（PDC）递送平台，开发下一代癌症靶向治疗方法，以期提高疗效并因脱靶效应减少而获得更好的安全性[7] - 公司产品管线包括主要资产：iopofosine I 131（一种旨在靶向递送碘-131的PDC）、基于锕-225的CLR 121225项目（针对胰腺癌等存在显著未满足需求的实体瘤）以及基于碘-125俄歇发射的CLR 121125项目（针对三阴性乳腺癌、肺癌和结直肠癌等其他实体瘤）[8] - iopofosine I 131已在复发或难治性多发性骨髓瘤和中枢神经系统淋巴瘤的2b期试验中进行研究，并在针对儿童高级别胶质瘤的CLOVER-2 1b期研究中应用，若获批公司有资格从FDA获得儿科审评券[9] - FDA已授予iopofosine I 131六项孤儿药认定、四项罕见儿科疾病认定和两项快速通道认定，针对多种癌症适应症[9]

NEW YORK, Oct. 07, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 70+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. To view the full publication, “When the Dollar Blinks, Real Assets Take Center Stage,” ...

Award-Winning, Clean-Label Pre & Post Workout Bundle Available InternationallyBELVIDERE, NJ, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic, and sustainable produce and products, today announced the international launch of its award-winning, clean-label Pre & Post Workout Kick. Sports Nutrition bundle at PriceSmart warehouse clubs. Kick. Sports Nutrition is ...

RESEARCH TRIANGLE PARK, N.C., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Data443 Risk Mitigation, Inc. (OTCPK: ATDS) (“Data443” or the “Company”), a data security and privacy software company for "All Things Data Security," today reaffirms its leadership in blockchain security and trusted ledger validation. With nearly a decade of experience at the forefront of data protection and digital ledger infrastructure, Data443 delivers robust security practices integrated with reliable decentralized validation, positioning ...

Geneva, Switzerland, Oct. 07, 2025 (GLOBE NEWSWIRE) -- SEALSQ’s CEO Carlos Moreira to Participate in the Panel: “Rewiring the Future with AI and Quantum Computing” —on October 7–9, 2025, SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, today announced its participation in the 10th Horasis Global Summit, to be held in São Paulo, Brazil, on October 7–9, 2025. This year’s summi ...

VANCOUVER, British Columbia, Oct. 07, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a business technology solution provider specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), Enterprise SaaS, and Quantum Computing solutions, announces that its Taipei, Taiwan-based Spider Vision Sensors (SVS) subsidiary has advanced to the commissioning phase and assembly line setup at its recently leased 16,000 square-foot drone components manufactur ...

ATLANTA, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Chart Industries, Inc. (NYSE: GTLS) (“Chart”), a global leader in energy and industrial gas solutions, plans to issue its third quarter 2025 earnings release prior to market open on October 29th. Chart will not host a webcast or conference call. About Chart Industries Chart Industries, Inc. is a global leader in the design, engineering, and manufacturing of process technologies and equipment for gas and liquid molecule handling for the Nexus of Clean™ - clean power ...